Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophrenia

Schizophrenia Research

Volumn 147, Issue 1, 2013, Pages 32-38

  Drummond, Jana B ^a   Tucholski, Janusz ^a   Haroutunian, Vahram ^b   Meador Woodruff, James H ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

AMPA receptor auxiliary protein; Glutamate receptor; Human; Postmortem; Trafficking

Indexed keywords

HALOPERIDOL DECANOATE; MESSENGER RNA; REGULATOR PROTEIN; TRANSMEMBRANE AMPA RECEPTOR REGULATORY PROTEIN; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GRAY MATTER; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SCHIZOPHRENIA; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; FEMALE; GENE EXPRESSION REGULATION; GYRUS CINGULI; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POSTMORTEM CHANGES; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 84877126705     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.03.010     Document Type: Article

References (74)

1. Allen R., Young S. Phencyclidine-induced psychosis. Am. J. Psychiatry 1978, 135(9):1081-1084.
2. Barbon A., Fumagalli F., La Via L., Caracciolo L., Racagni G., Andrea Riva M., Barlati S. Chronic phencyclidine administration reduces the expression and editing of specific glutamate receptors in rat prefrontal cortex. Exp. Neurol. 2007, 208(1):54-62.
3. Bats C., Groc L., Choquet D. The interaction between Stargazin and PSD-95 regulates AMPA receptor surface trafficking. Neuron 2007, 53(5):719-734.
4. Beneyto M., Meador-Woodruff J.H. Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia. Synapse 2006, 60(8):585-598.
5. Breese C.R., Freedman R., Leonard S.S. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res. 1995, 674(1):82-90.
6. Chen L., Bao S., Qiao X., Thompson R.F. Impaired cerebellar synapse maturation in waggler, a mutant mouse with a disrupted neuronal calcium channel gamma subunit. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(21):12132-12137.
7. Chen L., Chetkovich D.M., Petralia R.S., Sweeney N.T., Kawasaki Y., Wenthold R.J., Bredt D.S., Nicoll R.A. Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms. Nature 2000, 408(6815):936-943.
8. Chen L., El-Husseini A., Tomita S., Bredt D.S., Nicoll R.A. Stargazin differentially controls the trafficking of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate and kainate receptors. Mol. Pharmacol. 2003, 64(3):703-706.
9. Chen R.S., Deng T.C., Garcia T., Sellers Z.M., Best P.M. Calcium channel gamma subunits: a functionally diverse protein family. Cell Biochem. Biophys. 2007, 47(2):178-186.
10. Coombs I.D., Cull-Candy S.G. Transmembrane AMPA receptor regulatory proteins and AMPA receptor function in the cerebellum. Neuroscience 2009, 162(3):656-665.
11. Coyle J.T. The glutamatergic dysfunction hypothesis for schizophrenia. Harv. Rev. Psychiatry 1996, 3:241-253.
12. Coyle J.T., Tsai G., Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann. N. Y. Acad. Sci. 2003, 1003(1):318-327.
13. Dev K.K., Nishimune A., Henley J.M., Nakanishi S. The protein kinase C[alpha] binding protein PICK1 interacts with short but not long form alternative splice variants of AMPA receptor subunits. Neuropharmacology 1999, 38(5):635-644.
14. Díaz E. Regulation of AMPA receptors by transmembrane accessory proteins. Eur. J. Neurosci. 2010, 32(2):261-268.
15. Dracheva S., McGurk S.R., Haroutunian V. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics. J. Neurosci. Res. 2005, 79(6):868-878.
16. Eastwood S.L., McDonald B., Burnet P.W.J., Beckwith J.P., Kerwin R.W., Harrison P.J. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluRl and GluR2 in medial temporal lobe neurons in schizophrenia. Mol. Brain Res. 1995, 29(2):211-223.
17. Ellison G. The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res. Rev. 1995, 20(2):250-267.
18. Freed W.J., Dillon-Carter O., Kleinman J.E. Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide. Exp. Neurol. 1993, 121(1):48-56.
19. Funk A.J., McCullumsmith R.E., Haroutunian V., Meador-Woodruff J.H. Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia. Neuropsychopharmacology 2012, 37(4):896-905.
20. Funk A.J., Rumbaugh G., Harotunian V., McCullumsmith R.E., Meador-Woodruff J.H. Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia. Neuroreport 2009, 20(11):1019-1022.
21. Hammond J.C., McCullumsmith R.E., Funk A.J., Haroutunian V., Meador-Woodruff J.H. Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia. Neuropsychopharmacology 2010, 35:2110-2119.
22. Hanley J.G. AMPA receptor trafficking pathways and links to dendritic spine morphogenesis. Cell Adh. Migr. 2008, 2(4):276-282.
23. Harte M.K., Bachus S.B., Reynolds G.P. Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol. Schizophr. Res. 2005, 75(2-3):303-308.
24. Hashimoto K., Fukaya M., Qiao X., Sakimura K., Watanabe M., Kano M. Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. J. Neurosci. 1999, 19(14):6027-6036.
25. Healy D.J., Haroutunian V., Powchik P., Davidson M., Davis K.L., Watson S.J., Meador-Woodruff J.H. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics. Neuropsychopharmacology 1998, 19(4):278-286.
26. Jackson A.C., Nicoll R.A. The expanding social network of ionotropic glutamate receptors: TARPs and other transmembrane auxiliary subunits. Neuron 2011, 70(2):178-199.
27. Jackson A.C., Nicoll R.A. Stargazin (TARP gamma-2) is required for compartment-specific AMPA receptor trafficking and synaptic plasticity in cerebellar stellate cells. J. Neurosci. 2011, 31(11):3939-3952.
28. Kashihara K., Sato M., Fujiwara Y., Harada T., Ogawa T., Otsuki S. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain. Biol. Psychiatry 1986, 21(7):650-656.
29. Kato A.S., Gill M.B., Ho M.T., Yu H., Tu Y., Siuda E.R., Wang H., Qian Y.W., Nisenbaum E.S., Tomita S., Bredt D.S. Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. Neuron 2010, 68(6):1082-1096.
30. Kato A.S., Gill M.B., Yu H., Nisenbaum E.S., Bredt D.S. TARPs differentially decorate AMPA receptors to specify neuropharmacology. Trends Neurosci. 2010, 33(5):241-248.
31. Kato A.S., Siuda E.R., Nisenbaum E.S., Bredt D.S. AMPA receptor subunit-specific regulation by a distinct family of type II TARPs. Neuron 2008, 59(6):986-996.
32. Kato A.S., Zhou W., Milstein A.D., Knierman M.D., Siuda E.R., Dotzlaf J.E., Yu H., Hale J.E., Nisenbaum E.S., Nicoll R.A., Bredt D.S. New transmembrane AMPA receptor regulatory protein isoform, gamma-7, differentially regulates AMPA receptors. J. Neurosci. 2007, 27(18):4969-4977.
33. Klugbauer N., Dai S., Specht V., Lacinova L., Marais E., Bohn G., Hofmann F. A family of gamma-like calcium channel subunits. FEBS Lett. 2000, 470(2):189-197.
34. Kott S., Werner M., Korber C., Hollmann M. Electrophysiological properties of AMPA receptors are differentially modulated depending on the associated member of the TARP family. J. Neurosci. 2007, 27(14):3780-3789.
35. Lahti A.C., Koffel B., LaPorte D., Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 1995, 13(1):9-19.
36. Larionov A., Krause A., Miller W. A standard curve based method for relative real time PCR data processing. BMC Bioinformatics 2005, 6:62.
37. 2+-channel gamma subunit. Nat. Genet. 1998, 19(4):340-347.
38. Letts V.A., Mahaffey C.L., Beyer B., Frankel W.N. A targeted mutation in Cacng4 exacerbates spike-wave seizures in stargazer (Cacng2) mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(6):2123-2128.
39. Lu W., Ziff E.B. PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking. Neuron 2005, 47(3):407-421.
40. Malinow R., Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 2002, 25:103-126.
41. Meador-Woodruff J.H., Healy D.J. Glutamate receptor expression in schizophrenic brain. Brain Res. Brain Res. Rev. 2000, 31(2-3):288-294.
42. Menuz K., Kerchner G.A., O'Brien J.L., Nicoll R.A. Critical role for TARPs in early development despite broad functional redundancy. Neuropharmacology 2009, 56(1):22-29.
43. Menuz K., Nicoll R.A. Loss of inhibitory neuron AMPA receptors contributes to ataxia and epilepsy in stargazer mice. J. Neurosci. 2008, 28(42):10599-10603.
44. Menuz K., O'Brien J.L., Karmizadegan S., Bredt D.S., Nicoll R.A. TARP redundancy is critical for maintaining AMPA receptor function. J. Neurosci. 2008, 28(35):8740-8746.
45. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000, 28(1):53-67.
46. Mithani S., Atmadja S., Baimbridge K.G., Fibiger H.C. Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities. Psychopharmacology (Berl) 1987, 93(1):94-100.
47. Morimoto-Tomita M., Zhang W., Straub C., Cho C.H., Kim K.S., Howe J.R., Tomita S. Autoinactivation of neuronal AMPA receptors via glutamate-regulated TARP interaction. Neuron 2009, 61(1):101-112.
48. Nakagawa T., Sheng M. Neurobiology. A stargazer foretells the way to the synapse. Science 2000, 290(5500):2270-2271.
49. Noebels J.L., Qiao X., Bronson R.T., Spencer C., Davisson M.T. Stargazer: a new neurological mutant on chromosome 15 in the mouse with prolonged cortical seizures. Epilepsy Res. 1990, 7(2):129-135.
50. Noga J.T., Hyde T.M., Bachus S.E., Herman M.M., Kleinman J.E. AMPA receptor binding in the dorsolateral prefrontal cortex of schizophrenics and controls. Schizophr. Res. 2001, 48(2-3):361-363.
51. Opazo P., Choquet D. A three-step model for the synaptic recruitment of AMPA receptors. Mol. Cell. Neurosci. 2011, 46(1):1-8.
52. Osten P., Stern-Bach Y. Learning from stargazin: the mouse, the phenotype and the unexpected. Curr. Opin. Neurobiol. 2006, 16(3):275-280.
53. Powchik P., Davidson M., Haroutunian V., Gabriel S.M., Purohit D.P., Perl D.P., Harvey P.D., Davis K.L. Postmortem studies in schizophrenia. Schizophr. Bull. 1998, 24(3):325-341.
54. Rouach N., Byrd K., Petralia R.S., Elias G.M., Adesnik H., Tomita S., Karimzadegan S., Kealey C., Bredt D.S., Nicoll R.A. TARP gamma-8 controls hippocampal AMPA receptor number, distribution and synaptic plasticity. Nat. Neurosci. 2005, 8(11):1525-1533.
55. Sager C., Tapken D., Kott S., Hollmann M. Functional modulation of AMPA receptors by transmembrane AMPA receptor regulatory proteins. Neuroscience 2009, 158(1):45-54.
56. Scarr E., Beneyto M., Meador-Woodruff J.H., Dean B. Cortical glutamatergic markers in schizophrenia. Neuropsychopharmacology 2005, 30(8):1521-1531.
57. Schnell E., Sizemore M., Karimzadegan S., Chen L., Bredt D.S., Nicoll R.A. Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(21):13902-13907.
58. Schwenk J., Harmel N., Brechet A., Zolles G., Berkefeld H., Muller C.S., Bildl W., Baehrens D., Huber B., Kulik A., Klocker N., Schulte U., Fakler B. High-resolution proteomics unravel architecture and molecular diversity of native AMPA receptor complexes. Neuron 2012, 74(4):621-633.
59. Schwenk J., Harmel N., Zolles G., Bildl W., Kulik A., Heimrich B., Chisaka O., Jonas P., Schulte U., Fakler B., Klocker N. Functional proteomics identify cornichon proteins as auxiliary subunits of AMPA receptors. Science 2009, 323(5919):1313-1319.
60. Song I., Huganir R.L. Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci. 2002, 25(11):578-588.
61. Soto D., Coombs I.D., Kelly L., Farrant M., Cull-Candy S.G. Stargazin attenuates intracellular polyamine block of calcium-permeable AMPA receptors. Nat. Neurosci. 2007, 10(10):1260-1267.
62. Soto D., Coombs I.D., Renzi M., Zonouzi M., Farrant M., Cull-Candy S.G. Selective regulation of long-form calcium-permeable AMPA receptors by an atypical TARP, gamma-5. Nat. Neurosci. 2009, 12(3):277-285.
63. Suzuki E., Kessler M., Arai A.C. The fast kinetics of AMPA GluR3 receptors is selectively modulated by the TARPs gamma 4 and gamma 8. Mol. Cell. Neurosci. 2008, 38(1):117-123.
64. Tomita S. Regulation of ionotropic glutamate receptors by their auxiliary subunits. Physiology (Bethesda) 2010, 25(1):41-49.
65. Tomita S., Chen L., Kawasaki Y., Petralia R.S., Wenthold R.J., Nicoll R.A., Bredt D.S. Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins. J. Cell Biol. 2003, 161(4):805-816.
66. Tomita S., Fukata M., Nicoll R.A., Bredt D.S. Dynamic interaction of stargazin-like TARPs with cycling AMPA receptors at synapses. Science 2004, 303(5663):1508-1511.
67. Tomita S., Nicoll R.A., Bredt D.S. PDZ protein interactions regulating glutamate receptor function and plasticity. J. Cell Biol. 2001, 153(5):F19-F24.
68. Toyooka K., Iritani S., Makifuchi T., Shirakawa O., Kitamura N., Maeda K., Nakamura R., Niizato K., Watanabe M., Kakita A., Takahashi H., Someya T., Nawa H. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J. Neurochem. 2002, 83(4):797-806.
69. Vandenberghe W., Nicoll R.A., Bredt D.S. Stargazin is an AMPA receptor auxiliary subunit. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(2):485-490.
70. Whiteheart S.W., Matveeva E.A. Multiple binding proteins suggest diverse functions for the N-ethylmaleimide sensitive factor. J. Struct. Biol. 2004, 146(1-2):32-43.
71. Yamazaki M., Fukaya M., Hashimoto K., Yamasaki M., Tsujita M., Itakura M., Abe M., Natsume R., Takahashi M., Kano M., Sakimura K., Watanabe M. TARPs gamma-2 and gamma-7 are essential for AMPA receptor expression in the cerebellum. Eur. J. Neurosci. 2010, 31(12):2204-2220.
72. Zavitsanou K., Ward P.B., Huang X.F. Selective alterations in ionotropic glutamate receptors in the anterior cingulate cortex in schizophrenia. Neuropsychopharmacology 2002, 27(5):826-833.
73. Ziff E.B. TARPs and the AMPA receptor trafficking paradox. Neuron 2007, 53(5):627-633.
74. Zonouzi M., Renzi M., Farrant M., Cull-Candy S.G. Bidirectional plasticity of calcium-permeable AMPA receptors in oligodendrocyte lineage cells. Nat. Neurosci. 2011, 14(11):1430-1438.